Development and internal validation of a scoring model for early identification of ventricular arrhythmia risk in children with acute myocarditis

开发并进行内部验证,以建立用于早期识别急性心肌炎患儿室性心律失常风险的评分模型

阅读:4

Abstract

BACKGROUND: Early identification of ventricular arrhythmia (VA) risk in children with acute myocarditis (AMC) is challenging, as existing tools lack pediatric targeting. AMC’s non-specific early symptoms in children lead to underdiagnosis. VA, a major complication of AMC, is linked to poor prognosis, but not all cases present at admission, highlighting the need for simple, accessible predictive indicators. METHODS: This retrospective single-center study included 312 children (1 month − 17 years) with AMC (2021–2024), divided into a training set (n = 208, 2021–2023) and validation set (n = 104, 2024). Eligibility required first-time AMC diagnosis without admission VA. Univariate analysis (P < 0.05) and binary logistic regression identified independent VA risk factors. Continuous variables were dichotomized via receiver operating characteristic curves, and a scoring model was constructed, with internal validation of discriminative performance and calibration. RESULTS: Forty-four children (14.1%) developed VA, mostly within the first week. Independent risk factors were cardiac troponin I (cTnI ≥ 0.1945 ng/mL, OR = 9.114), blood urea nitrogen (BUN ≥ 4.55 mmol/L, OR = 9.796), and left ventricular fraction shortening (LVFS ≤ 0.33, OR = 6.005). The model assigned 3 points to cTnI/BUN and 2 to LVFS (total 0–8 points). At cutoff ≥ 4 points: training set (sensitivity = 70.0%, specificity = 90.4%, AUC = 0.871); validation set (sensitivity = 78.6%, specificity = 94.4%, accuracy = 92.3%, AUC = 0.837). Calibration was acceptable (Hosmer-Lemeshow P = 0.288). CONCLUSION: The cTnI-, BUN-, and LVFS-based scoring model offers a simple, effective tool for early VA risk stratification in children with AMC. It aids targeted monitoring and intervention, improving clinical decision-making. Limitations include retrospective single-center design and small sample size; prospective multicenter validation is needed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。